Serveur d'exploration sur le lymphœdème - Exploration (Accueil)

Index « Mesh.i » - entrée « Coumarins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cough < Coumarins < Counseling  Facettes :

List of bibliographic references indexed by Coumarins

Number of relevant bibliographic references: 82.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
001706 (2015) Elaine Y L. Leung [Royaume-Uni] ; Seema A. Tirlapur [Royaume-Uni] ; Catherine Meads [Royaume-Uni]The management of secondary lower limb lymphoedema in cancer patients: a systematic review.
003D85 (2012) Hanneke G M. Wittgen [Pays-Bas] ; Jeroen J M W. Van Den Heuvel ; Petra H H. Van Den Broek ; Sanna Siissalo ; Geny M M. Groothuis ; Inge A M. De Graaf ; Jan B. Koenderink ; Frans G M. RusselTransport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
005B57 (2010) Klaus Abraham [Allemagne] ; Friederike Wöhrlin [Allemagne] ; Oliver Lindtner [Allemagne] ; Gerhard Heinemeyer [Allemagne] ; Alfonso Lampen [Allemagne]Toxicology and risk assessment of coumarin: Focus on human data
006614 (2009) R. L. Satarasinghe ; M. A. R. JayawardanaLympidem® (a Coumarin Derivative) Induced Reversible Hepatotoxicity in an Adult Sri Lankan
007326 (2007) Nicholas Farinola [Australie] ; Neil B. PillerCYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?
007F17 (2005) Nicholas Farinola [Australie] ; Neil PillerPharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema.
007F53 (2005) Stanley G. RocksonLymphatic research: a global concern.
008854 (2004) C. Badger ; N. Preston ; K. Seers ; Peter Mortimer (dermatologue)‎ [Royaume-Uni]Benzo-pyrones for reducing and controlling lymphoedema of the limbs.
009310 (2002) V. Boursier [France][Lymphedema: which drug therapy?].
00A552 (2000) Albert-Adrien Ramelet [Suisse]Pharmacologic Aspects of a Phlebotropic Drug in CVI-Associated Edema
00A908 (2000) Judith R. Casley-Smith [Australie]Changes in the microcirculation at the superficial and deeper levels in lymphoedema: the effects and results of massage, compression, exercise and benzopyrones on these levels during treatment
00A962 (1999) P A GanzThe quality of life after breast cancer--solving the problem of lymphedema.
00A964 (1999) C L WitteThe placebo "arm".
00AA38 (1999) R. TwycrossBenzopyrones and the placebo "arm".
00AA50 (1999) M E O'RourkeAdvances in symptom management: lymphedema.
00AB82 (1999) D. E Goeger [États-Unis] ; A. W Hsie [États-Unis] ; K. E Anderson [États-Unis]Co-mutagenicity of Coumarin (1,2-benzopyrone) with Aflatoxin B1 and Human Liver S9 in Mammalian Cells
00AE34 (1999) Susan Alder [Australie]GUIDELINES FOR THE SURGICAL MANAGEMENT OF BREAST CANCER: COMMENT
00B003 (1999) C. L. Loprinzi [États-Unis] ; J. W. Kugler [États-Unis] ; J. A. Sloan [États-Unis] ; T. W. Rooke [États-Unis] ; S. K. Quella [États-Unis] ; P. Novotny [États-Unis] ; R. B. Mowat [États-Unis] ; J. C. Michalak [États-Unis] ; P. J. Stella [États-Unis] ; R. Levitt [États-Unis] ; L. K. Tschetter [États-Unis] ; H. Windschitl [États-Unis]Lack of effect of coumarin in women with lymphedema after treatment for breast cancer
00B011 (1999) A. Burgos [Espagne] ; A. Alcaide [Espagne] ; C. Alcoba [Espagne] ; J. M. Azcona [Espagne] ; J. Garrido [Espagne] ; C. Lorente ; E. Moreno [Espagne] ; E. Murillo [Espagne] ; J. Olsina-Pavia [Espagne] ; J. Olsina-Kissler [Espagne] ; E. Samaniego [Espagne] ; M. Serra [Espagne]Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer
00B019 (1999) J. R. Casley-Smith [Australie]Benzo-pyrones in the treatment of lymphoedema
00B045 (1998) H. Hadidi ; Y. Irshaid ; C B V Gb ; A. Brunsvik ; S. Cholerton ; K. Zahlsen ; J R IdleVariability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Coumarins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Coumarins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Coumarins
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024